Nintedanib Capsules, 100 Mg And 150 Mg Capsule
Product Images NDC 76282-786

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nintedanib Capsules, 100 Mg And 150 Mg (NDC 76282-786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 02)

FDA Label Image

Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 03)

FDA Label Image

Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 04)

This text provides information on survival estimates using the Kapkan-Mhese methodology, with a hazard ratio of 0.70 and further details on death over 52 weeks.*

FDA Label Image

Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 05)

FDA Label Image

Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 06)

FDA Label Image

Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 07)

FDA Label Image

Exelan-100mg-label (Exelan 100mg Label)

This text is not readable.*

FDA Label Image

Exelan-150mg-label (Exelan 150mg Label)

Not available.*

FDA Label Image

Figure-7 (Figure 7)

FDA Label Image

Figure-8 (Figure 8)

FDA Label Image

Figure-9 (Figure 9)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.